Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05781620
Other study ID # N202205045
Secondary ID NSTC111-2410-H-0
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 21, 2022
Est. completion date February 2024

Study information

Verified date February 2023
Source Taipei Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effects of vitamin D supplementation on biochemistry response and skeletal muscle synthesis in prolonged endurance exercise.


Description:

Endurance exercise mode will be used to evaluate the effects of vitamin D supplementation on cardiac biomarkers, metabolic hormones, oxidative damage, and inflammation responses. An independent samples and dose titration design will be used to assign 30 participants to the experimental group (n = 15) or placebo group (n = 15). All participants in the experimental group will have serum 25(OH)D concentrations higher than 48 ng/mL after supplementation period. After the prolonged endurance exercise test, the blood samples will be collected for analyzing biomarkers. Data will be analyzed by Two-way mixed design ANOVA.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 50
Est. completion date February 2024
Est. primary completion date February 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 40 Years
Eligibility Inclusion criteria: - The volunteers included have conditions as stated below : 1. male adult between 20-40 years old without any history of cardiovascular, liver, kidney and diabetes disease 2. no acute sport injury 3. male adult whose concentration of 25(OH)D is under 30 ng/mL, and maximal oxygen consumption is over 40 ml/kg/min 4. did not participated in any clinical trials or research in the last 3 months before our experiment 5. no supplements were taken during the experimental period 6. were requested to maintain their regular daily life style and avoid alcohol intake Exclusion Criteria: - The volunteers were excluded if they have the situation stated below: 1. history of cardiovascular, liver, kidney and diabetes disease 2. acute sport injury 3. their concentration of 25(OH)D is over 30 ng/mL, or maximal oxygen consumption is under 40 ml/kg/mint 4. participated in any clinical trials or experimental research in the last 3 months before our experiment 5. taking supplement during the experimental period 6. did not maintain their regular eating habit or drink alcohol

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Vitamin D
Participants received 5,000 IU of vitamin D orally twice daily for 4 weeks. If the serum 25(OH)D concentration exceeds 48 ng/mL, the intervention remains the same. However, if the serum 25(OH)D concentration is under 48 ng/mL, the dosage would increase by 2,500 IU. The principle remains the same at week 6.
Medium-chain triglycerides
Participants received the same amount of placebo matching vitamin D orally twice daily.

Locations

Country Name City State
Taiwan Taipei Medical University Taipei

Sponsors (2)

Lead Sponsor Collaborator
Taipei Medical University Panion & BF Biotech Inc.

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Concentration of NT-proBNP before exercise
Primary Concentration of NT-proBNP immediately after exercise
Primary Concentration of NT-proBNP 2-hour after exercise
Primary Concentration of NT-proBNP 24-hour after exercise
Primary Concentration of cTnI before exercise
Primary Concentration of cTnI immediately after exercise
Primary Concentration of cTnI 2-hour after exercise
Primary Concentration of cTnI 24-hour after exercise
Primary Concentration of CK-MB before exercise
Primary Concentration of CK-MB immediately after exercise
Primary Concentration of CK-MB 2-hour after exercise
Primary Concentration of CK-MB 24-hour after exercise
Primary Concentration of CK before exercise
Primary Concentration of CK immediately after exercise
Primary Concentration of CK 2-hour after exercise
Primary Concentration of CK 24-hour after exercise
Primary Concentration of Testosterone before exercise
Primary Concentration of Testosterone immediately after exercise
Primary Concentration of Testosterone 2-hour after exercise
Primary Concentration of Testosterone 24-hour after exercise
Primary Concentration of Cortisol before exercise
Primary Concentration of Cortisol immediately after exercise
Primary Concentration of Cortisol 2-hour after exercise
Primary Concentration of Cortisol 24-hour after exercise
Primary Concentration of ß-endorphin before exercise
Primary Concentration of ß-endorphin immediately after exercise
Primary Concentration of ß-endorphin 2-hour after exercise
Primary Concentration of ß-endorphin 24-hour after exercise
Primary Concentration of Growth hormone before exercise
Primary Concentration of Growth hormone immediately after exercise
Primary Concentration of Growth hormone 2-hour after exercise
Primary Concentration of Growth hormone 24-hour after exercise
Primary Concentration of IGF-1 before exercise
Primary Concentration of IGF-1 immediately after exercise
Primary Concentration of IGF-1 2-hour after exercise
Primary Concentration of IGF-1 24-hour after exercise
Primary Concentration of TBARS before exercise
Primary Concentration of TBARS immediately after exercise
Primary Concentration of TBARS 2-hour after exercise
Primary Concentration of TBARS 24-hour after exercise
Primary Concentration of PC before exercise
Primary Concentration of PC immediately after exercise
Primary Concentration of PC 2-hour after exercise
Primary Concentration of PC 24-hour after exercise
Primary Concentration of SOD before exercise
Primary Concentration of SOD immediately after exercise
Primary Concentration of SOD 2-hour after exercise
Primary Concentration of SOD 24-hour after exercise
Primary Concentration of Catalase before exercise
Primary Concentration of Catalase immediately after exercise
Primary Concentration of Catalase 2-hour after exercise
Primary Concentration of Catalase 24-hour after exercise
Primary Concentration of TNF-a before exercise
Primary Concentration of TNF-a immediately after exercise
Primary Concentration of TNF-a 2-hour after exercise
Primary Concentration of TNF-a 24-hour after exercise
Primary Concentration of IL-8 before exercise
Primary Concentration of IL-8 immediately after exercise
Primary Concentration of IL-8 2-hour after exercise
Primary Concentration of IL-8 24-hour after exercise
Primary Concentration of IL-10 before exercise
Primary Concentration of IL-10 immediately after exercise
Primary Concentration of IL-10 2-hour after exercise
Primary Concentration of IL-10 24-hour after exercise
Primary Concentration of LDH before exercise
Primary Concentration of LDH immediately after exercise
Primary Concentration of LDH 2-hour after exercise
Primary Concentration of LDH 24-hour after exercise
Primary Concentration of IL-6 before exercise
Primary Concentration of IL-6 immediately after exercise
Primary Concentration of IL-6 2-hour after exercise
Primary Concentration of IL-6 24-hour after exercise
Primary Concentration of IL-15 before exercise
Primary Concentration of IL-15 immediately after exercise
Primary Concentration of IL-15 2-hour after exercise
Primary Concentration of IL-15 24-hour after exercise
Primary Concentration of leukocyte before exercise
Primary Concentration of leukocyte immediately after exercise
Primary Concentration of leukocyte 2-hour after exercise
Primary Concentration of leukocyte 24-hour after exercise
Primary Concentration of neutrophil before exercise
Primary Concentration of neutrophil immediately after exercise
Primary Concentration of neutrophil 2-hour after exercise
Primary Concentration of neutrophil 24-hour after exercise
Primary Concentration of eosinophil before exercise
Primary Concentration of eosinophil immediately after exercise
Primary Concentration of eosinophil 2-hour after exercise
Primary Concentration of eosinophil 24-hour after exercise
Primary Concentration of basophil before exercise
Primary Concentration of basophil immediately after exercise
Primary Concentration of basophil 2-hour after exercise
Primary Concentration of basophil 24-hour after exercise
Primary Concentration of monocyte before exercise
Primary Concentration of monocyte immediately after exercise
Primary Concentration of monocyte 2-hour after exercise
Primary Concentration of monocyte 24-hour after exercise
Primary Concentration of lymphocyte before exercise
Primary Concentration of lymphocyte immediately after exercise
Primary Concentration of lymphocyte 2-hour after exercise
Primary Concentration of lymphocyte 24-hour after exercise
Primary Concentration of CD4+ before exercise
Primary Concentration of CD4+ immediately after exercise
Primary Concentration of CD4+ 2-hour after exercise
Primary Concentration of CD4+ 24-hour after exercise
Primary Concentration of CD8+ before exercise
Primary Concentration of CD8+ immediately after exercise
Primary Concentration of CD8+ 2-hour after exercise
Primary Concentration of CD8+ 24-hour after exercise
Primary Concentration of CD19+ before exercise
Primary Concentration of CD19+ immediately after exercise
Primary Concentration of CD19+ 2-hour after exercise
Primary Concentration of CD19+ 24-hour after exercise
Primary Concentration of CD56+ before exercise
Primary Concentration of CD56+ immediately after exercise
Primary Concentration of CD56+ 2-hour after exercise
Primary Concentration of CD56+ 24-hour after exercise
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1